{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:59:03Z","timestamp":1787018343464,"version":"build-2736575974"},"reference-count":32,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"13","license":[{"start":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2020,12,4]]},"DOI":"10.1167\/tvst.9.13.6","type":"journal-article","created":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T01:47:03Z","timestamp":1607132823000},"page":"6","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy of Topical Carbonic Anhydrase Inhibitors in Reducing Duration of Chronic Central Serous Chorioretinopathy"],"prefix":"10.1167","volume":"9","author":[{"given":"Gerald","family":"Liew","sequence":"first","affiliation":[{"name":"Centre for Vision Research, Department of Ophthalmology (Westmead Hospital), the Westmead Institute for Medical Research, University of Sydney, NSW, Australia"},{"name":"Retina Associates, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Van","family":"Ho","sequence":"additional","affiliation":[{"name":"Retina Associates, Sydney, NSW, Australia"},{"name":"Retina Unit, Sydney Eye Hospital, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Ong","sequence":"additional","affiliation":[{"name":"Retina Associates, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bamini","family":"Gopinath","sequence":"additional","affiliation":[{"name":"Centre for Vision Research, Department of Ophthalmology (Westmead Hospital), the Westmead Institute for Medical Research, University of Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Centre for Vision Research, Department of Ophthalmology (Westmead Hospital), the Westmead Institute for Medical Research, University of Sydney, NSW, Australia"},{"name":"Sydney West Retina, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/ceo.2013.41.issue-2","article-title":"Diagnosis and interventions for central serous chorioretinopathy: review and update","volume":"41","author":"Quin","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/ceo.2013.41.issue-2","article-title":"Central serous chorioretinopathy: a review of epidemiology and pathophysiology","volume":"41","author":"Liew","year":"2013","journal-title":"Clin Exp Ophthalmology"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"100770","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: towards an evidence-based treatment guideline","volume":"73","author":"van Rijssen","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ophtha.2018.12.048","article-title":"Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy","volume":"126","author":"Mrejen","year":"2019","journal-title":"Ophthalmology"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1167\/iovs.19-26781","article-title":"Elevated steroid hormone levels in active chronic central serous chorioretinopathy","volume":"60","author":"Schellevis","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib6","first-page":"472","article-title":"Electrophysiological effects of corticosteroids on the retinal pigment epithelium","volume":"42","author":"Arndt","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2019.03.025","article-title":"Focal and diffuse chronic central serous chorioretinopathy treated with half-dose photodynamic therapy or subthreshold micropulse laser: PLACE Trial Report No. 3","volume":"205","author":"van Rijssen","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ajo.2016.04.001","article-title":"Half-dose versus half-time photodynamic therapy for central serous chorioretinopathy","volume":"167","author":"Liu","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.ophtha.2008.04.014","article-title":"Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial","volume":"115","author":"Chan","year":"2008","journal-title":"Ophthalmology"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","article-title":"Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE Trial","volume":"125","author":"van Dijk","year":"2018","journal-title":"Ophthalmology"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ajo.2016.07.026","article-title":"A multicenter study on the long-term outcomes of half-dose photodynamic therapy in chronic central serous chorioretinopathy","volume":"170","author":"Lai","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0002-9394(83)90265-9","article-title":"Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy","volume":"95","author":"Robertson","year":"1983","journal-title":"Am J Ophthalmol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1097\/IAE.0000000000001649","article-title":"A randomised double blind placebo controlled pilot study of eplerenone for treatment of central serous chorioretinopathy","volume":"38","author":"Rahimy","year":"2018","journal-title":"Retina (Philadelphia, PA)"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/IAE.0000000000001913","article-title":"Comparison of short term efficacy between oral spironolactone and photodynamic therapy for central serous chorioretinopathy","volume":"39","author":"Lee","year":"2019","journal-title":"Retina (Philadelphia, PA)"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"107754","DOI":"10.1016\/j.exer.2019.107754","article-title":"Mineralocorticoid antagonists in the treatment of central serous chorioretinopathy: review of the pre-clinical and clinical evidence","volume":"187","author":"Bousquet","year":"2019","journal-title":"Exp Eye Res"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/IAE.0000000000001917","article-title":"Twelve month efficacy of intravitreal bevacizumab for chronic recurrent central serous chorioretinopathy","volume":"39","author":"Chung","year":"2019","journal-title":"Retina (Philadelphia, PA)"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00417-015-2989-z","article-title":"Oral Rifampin treatment for longstanding chronic central serous chorioretinopathy","volume":"254","author":"Shulman","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1097\/IAE.0b013e31821c3ef6","article-title":"Oral mifepristone for chronic central serous chorioretinopathy","volume":"31","author":"Nielsen","year":"2011","journal-title":"Retina (Philadelphia, PA)"},{"key":"bib19","first-page":"3401","article-title":"Membrane-bound carbonic anhydrase in human retinal pigment epithelium","volume":"35","author":"Wolfensberger","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1023\/A:1002143802926","article-title":"The role of carbonic anhydrase inhibitors in the management of macular edema","volume":"97","author":"Wolfensberger","year":"1999","journal-title":"Doc Ophthalmol"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/archopht.1988.01060140350030","article-title":"Treatment of chronic macular edema with acetazolamide","volume":"106","author":"Cox","year":"1988","journal-title":"Arch Ophthalmol (Chicago, Ill: 1960)"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1167\/iovs.14-15995","article-title":"Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa","volume":"56","author":"Liew","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/00006982-199717030-00009","article-title":"Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa","volume":"17","author":"Grover","year":"1997","journal-title":"Retina (Philadelphia, PA)"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10633-015-9496-8","article-title":"Rapid resolution of retinoschisis with acetazolamide","volume":"131","author":"Zhang","year":"2015","journal-title":"Doc Ophthalmol"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0161-6420(02)01157-0","article-title":"Acetazolamide for central serous retinopathy","volume":"109","author":"Pikkel","year":"2002","journal-title":"Ophthalmology"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/OPX.0000000000001394","article-title":"Combined topical anti-inflammatory and oral acetazolamide in the treatment of central serous chorioretinopathy","volume":"96","author":"Wuarin","year":"2019","journal-title":"Optom Vis Sci"},{"key":"bib27","first-page":"142","article-title":"Membrane-bound carbonic anhydrase activity in the rat corneal endothelium and retina","volume":"40","author":"Terashima","year":"1996","journal-title":"Jpn J Ophthalmol"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1167\/iovs.12-10991","article-title":"Optical coherence tomography-assisted enhanced depth imaging of central serous chorioretinopathy","volume":"54","author":"Yang","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/bjophthalmol-2016-309247","article-title":"Preferred practice pattern in central serous chorioretinopathy","volume":"101","author":"Mehta","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s004170050013","article-title":"Inhibition of membrane-bound carbonic anhydrase enhances subretinal fluid absorption and retinal adhesiveness","volume":"238","author":"Wolfensberger","year":"2000","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41433-018-0158-4","article-title":"Pachychoroid disease","volume":"33","author":"Cheung","year":"2019","journal-title":"Eye (London, England)"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/IAE.0000000000001138","article-title":"Comparison of photodynamic therapy using half-dose of verteporfin or half-fluence of laser light for the treatment of chronic central serous chorioretinopathy","volume":"37","author":"Cheng","year":"2017","journal-title":"Retina (Philadelphia, PA)"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2772037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T01:47:05Z","timestamp":1607132825000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2772037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,4]]},"references-count":32,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.9.13.6","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,4]]}}}